(Date:11/20/2008)...umption of illicit or noncommercial alcohol is wid...s significantly to the global burden of disease, a...ernational Center for Alcohol Policies (ICAP). The...l, defined as traditional beverages produced for h...feit or unregistered products, in three regions: s...
(Date:11/20/2008)... results in review of national program , ...l cancer screening detects 40 percent of cancers a...e, say Finnish Cancer Registry researchers. , T...rmine how sensitive Finland,s colorectal cancer sc...sease. Half the people were assigned to a screenin...
(Date:11/20/2008)...spiratory disease , , THURSDAY, Nov. 20 ...ng ovulation may explain why women with cystic fib...tory disease, researchers at the University of Nor..., published in the Nov. 20 issue of the Journal o... reduce estrogen levels, such as tamoxifen, might ...
(Date:11/20/2008)... The National Minority Quality Forum (NMQF) today ...t decision to develop a Health Insurer Code of Con... to join the Forum in encouraging adoption and com...sicians and lawyers -- even politicians -- follow ...nt and Chief Executive Officer of the Forum. "It,s...
Breaking Medicine News(10 mins):Health News:Report finds extensive use of illicit alcohol 2Health News:Colorectal Cancer Screens Detect Unrecognized Disease 2Health News:Estrogen May Explain Why Women With Cystic Fibrosis Suffer More 2Health News:Estrogen May Explain Why Women With Cystic Fibrosis Suffer More 3Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2(Date:11/20/2008)...ILADELPHIA, Nov. 20 Glaxo... United States Food and Drug Administration (FDA) ...ombopag) for the treatment of thrombocytopenia in ...ytopenic purpura (ITP) who have had an insufficien...splenectomy. The approval is a significant milesto...
(Date:11/20/2008)... Milk. It does a body good. And,n...ht. After years of,research, scientists at OncoNu...,s milk that stimulate the body,s own production o...a News Release, go to:, http://www.prnewswire.com/...ing new cancer therapies, the chief scientist, Dr....
(Date:11/20/2008)... Radius Health ("Radius") announced...n to its second institutional financing round, inc... and the total amount raised since the company,s i...onal investors participated in the financing, led ... Capital, The Wellcome Trust, HealthCare Ventures,...
(Date:11/20/2008)...er 20 The Scandinavian-based drug,... results of studies on its,lead antimicrobial can...DC,the studies showed that the novel lytic pepti..., significantly better towards killing Staphylococ...ed gold standard drugs. In,addition to this it ha...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Melanomas may appear noticeably different than other moles 9848 1Melanomas may appear noticeably different than other moles 9848 2Exercise Program Eases Arthritis 9844 1Exercise Program Eases Arthritis 9844 2Greenway Experiences Quick Success in the Community EHR Marketplace by Securing Contracts with 10 Community Based Health Organizations 9840 1Greenway Experiences Quick Success in the Community EHR Marketplace by Securing Contracts with 10 Community Based Health Organizations 9840 2Greenway Experiences Quick Success in the Community EHR Marketplace by Securing Contracts with 10 Community Based Health Organizations 9840 3Greenway Experiences Quick Success in the Community EHR Marketplace by Securing Contracts with 10 Community Based Health Organizations 9840 4Greenway Experiences Quick Success in the Community EHR Marketplace by Securing Contracts with 10 Community Based Health Organizations 9840 5Benefitfocus 28R 29 Expands Reach to Consumers With ConnectYourCare Partnership 9836 1Benefitfocus 28R 29 Expands Reach to Consumers With ConnectYourCare Partnership 9836 2Benefitfocus 28R 29 Expands Reach to Consumers With ConnectYourCare Partnership 9836 3...ro-Pharmaceuticals,Inc. (Amex: PRW), a company "A...ated the progress of its Phase II,clinical trial f...e,colorectal cancer patients who are unable to tol... II clinical trial for first-line,treatment of bil...ns may represent orphan drug status for DAVANAT(R)...
...ugar Biotechnology,Inc. (OTCBB:CGRB) today announ... Company,s prostate cancer drug candidate CB7630,(...n Society for,Medical Oncology (ESMO) Conference, ...land. The data were presented in two oral and,post... session for,genitourinary (prostate) cancer that ...
Other Medicine Technology:Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 6Ammonia/Alcohol Control is intended as a means of monitoring various ammonia and ethanol assay methods. This ready-to-use, three-level control is targeted at clinically significant levels of ammonia
This unassayed control is intended as a means of monitoring manual and automated assay methods used for the quantitation of oxalate in human urine samples. This control is ready-to-use liquid, requir
Microbumin is a two-level control compatible with popular strips such as Clinitek Microalbumin Reagent Strips and Roche Micral test strips. This control is also suitable for turbidimetric immunoassay
...rol monitors the performance of Abuscreen ONLINE, ...ening methods. This control meets current revised ...Mental Health Services Administration (SAMSHA). Le...s below screening cut-off levels (negative thresho...
Medicine Products: